Literature DB >> 17893991

Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis.

Yaniv Sherer1, Marco Matucci Cerinic, Francesca Bartoli, Jelena Blagojevic, Maria Letizia Conforti, Boris Gilburd, Michael Ehrenfeld, Yehuda Shoenfeld.   

Abstract

Autoimmune diseases are characterized by enhanced atherosclerosis. Humoral immune responses to mycobacterial HSP-65, human HSP-60, and to oxLDL have been established in a number of human autoimmune diseases and are considered to be associated with atherosclerosis. The aim of this study was to evaluate carotid artery intima-media thickness (IMT) in patients having systemic sclerosis (SSc) and to find out whether early atherosclerosis is associated with these autoantibodies. Forty-four patients having SSc underwent clinical evaluation and carotid artery IMT measurement. Several autoantibodies were tested among patients and a control group. The antibodies against human HSP-60 were measured by antihuman (IgG/IgM) HSP-60 ELISA kit. IgGs and IgMs antimycobacterial HSP-65 were determined using an ELISA with mycobacterial recombinant HSP-65 antigens. Similarly, anti-oxLDL antibodies were measured by an ELISA kit. Abnormal IMT levels were significantly more common in SSc patients compared with control subjects. Age was found as the sole most significant clinical parameter associated with carotid artery IMT in SSc. Disease duration, type of SSc, lung function tests, and cardiovascular risk factors were not associated with IMT in these patients. Levels of HSP-60, HSP-65, and oxLDL autoantibodies were similar among patients compared with controls, and in patients having "positive" IgM anti-HSP-65, higher IMT values were found. Abnormal carotid IMT is more prevalent in SSc than in normal subjects. Age rather than other clinical parameters is associated with early atherosclerotic changes in SSc. Autoantibodies to oxLDL, HSP-60, and HSP-65 are not elevated in SSc and there is only a borderline association with carotid artery IMT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893991     DOI: 10.1196/annals.1422.028

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  Atherosclerosis in Systemic Sclerosis: a Modern Controversy.

Authors:  Stefania L Magda; Raluca I Mincu; Carmen M Mihai; Mircea Cinteza; Dragos Vinereanu
Journal:  Maedica (Buchar)       Date:  2015-09

Review 2.  A critical view on cardiovascular risk in systemic sclerosis.

Authors:  Antonios Psarras; Stergios Soulaidopoulos; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2016-07-12       Impact factor: 2.631

Review 3.  Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.

Authors:  Karen Au; Manjit K Singh; Vijay Bodukam; Sangmee Bae; Paul Maranian; Rikke Ogawa; Brennan Spiegel; Maureen McMahon; Bevra Hahn; Dinesh Khanna
Journal:  Arthritis Rheum       Date:  2011-07

4.  Serum salusin-α levels in systemic lupus erythematosus and systemic sclerosis.

Authors:  Süleyman Serdar Koca; Metin Özgen; Bahar Işık; Mustafa Necati Dağlı; Bilal Üstündağ; Ahmet Işık
Journal:  Eur J Rheumatol       Date:  2014-03-01

5.  Risk factors for coronary heart disease in connective tissue diseases.

Authors:  Awal Al Husain; Ian N Bruce
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-06       Impact factor: 5.346

Review 6.  Cardiovascular disease in systemic sclerosis.

Authors:  Francesca Cannarile; Valentina Valentini; Giulia Mirabelli; Alessia Alunno; Riccardo Terenzi; Filippo Luccioli; Roberto Gerli; Elena Bartoloni
Journal:  Ann Transl Med       Date:  2015-01

Review 7.  Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.

Authors:  Hasya Zinger; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

8.  The Role of Immunogenicity in Cardiovascular Disease.

Authors:  Michael Jan; Anthony T Virtue; Meghanaben Pansuria; Jingshan Liu; Xinyu Xiong; Pu Fang; Shu Meng; Hong Wang; Xiao-Feng Yang
Journal:  World Heart J       Date:  2011-01-01

9.  Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease.

Authors:  Edit Bodolay; Zoltan Prohászka; Gyorgy Paragh; Istvan Csipő; Gabor Nagy; Renata Laczik; Nora Demeter; Eva Zöld; Britt Nakken; Gyula Szegedi; Peter Szodoray
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

Review 10.  Cardiovascular disease in systemic sclerosis--an emerging association?

Authors:  Gene-Siew Ngian; Joanne Sahhar; Ian P Wicks; Sharon Van Doornum
Journal:  Arthritis Res Ther       Date:  2011-08-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.